Northwestern Mutual Wealth Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
JT
Northwestern Mutual Wealth Management's PTCT Position: Q2 2026 in Review
Northwestern Mutual Wealth Management increased its PTC Therapeutics (PTCT) stake by 2.3% in Q2 2026, buying an estimated $2.46K and bringing the position to 1,487 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2197.
Northwestern Mutual Wealth Management first reported a position in PTCT in Q2 2016 and has held it in 25 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Northwestern Mutual Wealth Management held 1,487 shares of PTC Therapeutics worth $121K as of Q2 2026.
- Northwestern Mutual Wealth Management bought 34 PTC Therapeutics shares in Q2 2026, an estimated $2.46K.
- PTC Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2197 holding.
- Northwestern Mutual Wealth Management first reported a position in PTC Therapeutics in Q2 2016 and has held it in 25 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.